BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12487391)

  • 1. Genetic variability of hepatitis C virus in dialysis: the implications.
    Fabrizi F; Lunghi G; Poordad FF; Martin P
    Int J Artif Organs; 2002 Nov; 25(11):1034-48. PubMed ID: 12487391
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatitis C virus in chronic dialysis patients.
    Natov SN; Pereira BJ
    Minerva Urol Nefrol; 2005 Sep; 57(3):175-97. PubMed ID: 15986016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in hemodialysis patients.
    Vidales-Braz BM; da Silva NM; Lobato R; Germano FN; da Mota LD; Barros EJ; de Martinez AM
    Virol J; 2015 Feb; 12():8. PubMed ID: 25644891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prevalence of hepatitis C virus infection among chronic hemodialysis patients].
    Tuyuguchi M; Saitou M; Kukita K; Kawamura A
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):319-22. PubMed ID: 15359812
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C virus infection in dialysis and renal transplantation.
    Pereira BJ; Levey AS
    Kidney Int; 1997 Apr; 51(4):981-99. PubMed ID: 9083262
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis C virus infection in end stage renal disease and after kidney transplant.
    Rodriguez-Castro KI; Morisco F; Rigotti P; Rugge M; Burra P
    J Gastrointestin Liver Dis; 2014 Sep; 23(3):340-2. PubMed ID: 25267966
    [No Abstract]   [Full Text] [Related]  

  • 7. Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric French survey.
    Sauné K; Kamar N; Miédougé M; Weclawiak H; Dubois M; Izopet J; Rostaing L
    Nephrol Dial Transplant; 2011 Jul; 26(7):2309-16. PubMed ID: 21097646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C infection in dialysis patients in Israel.
    Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
    Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Viral hepatitis C in patients with terminal chronic renal insufficiency. III. Viral quantification].
    González-Michaca L; Soto-Ramírez LE; Rodríguez R; Gamba G
    Rev Invest Clin; 2001; 53(1):21-7. PubMed ID: 11332047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The presence of hepatitis C virus (HCV) infection in hemodialysis patients and determination of HCV genotype distribution].
    Bozdayi G; Rota S; Verdi H; Derici U; Sindel S; Bali M; Başay T
    Mikrobiyol Bul; 2002; 36(3-4):291-300. PubMed ID: 12838663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Viral hepatitis in hemodialysis patients].
    Yanai M
    Rinsho Byori; 2001 Mar; 49(3):249-53. PubMed ID: 11307324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic discordance for hepatitis C virus infection in hemodialysis: correlations with clinical and laboratory features.
    Stefanidis I; Liakopoulos V; Rigopoulou EI; Dalekos GN
    Am J Kidney Dis; 2005 Nov; 46(5):992-3; author reply 993. PubMed ID: 16253745
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective study of hepatitis C virus infection in hemodialysis patients by monthly analysis of HCV RNA and antibodies.
    Moreira R; Pinho JR; Fares J; Oba IT; Cardoso MR; Saraceni CP; Granato C
    Can J Microbiol; 2003 Aug; 49(8):503-7. PubMed ID: 14608385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hepatitis C virus on hemoglobin and hematocrit levels in saudi hemodialysis patients.
    Alsaran KA; Sabry AA; Alghareeb AH; Al Sadoon G
    Ren Fail; 2009; 31(5):349-54. PubMed ID: 19839833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of anti-hepatitis C virus antibodies and hepatitis C virus viraemia in chronic haemodialysis patients in Libya.
    Elzouki AN; Bushala M; Tobji RS; Khfaifi M
    Nephrol Dial Transplant; 1995; 10(4):475-6. PubMed ID: 7542751
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatitis C virus infection among long-term hemodialysis patients].
    Lu A; Wang A; Sheng R
    Zhonghua Nei Ke Za Zhi; 1997 Jun; 36(6):402-5. PubMed ID: 10374301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Current status of the prevalence, diagnosis, and treatment of hepatitis C in patients undergoing hemodialysis].
    Yang GL; Lei XZ
    Zhonghua Gan Zang Bing Za Zhi; 2017 Mar; 25(3):233-236. PubMed ID: 28482415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of hepatitis C virus infection in patients with chronic kidney disease on conservative therapy.
    Li Cavoli G; Ferrantelli A; Bono L; Tortorici C; Giammarresi C; Zagarrigo C; Schillaci O; Tralongo A; Soresi M; Rotolo U
    Int J Infect Dis; 2011 Aug; 15(8):e514-6. PubMed ID: 21680217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus antibody and hepatitis C viremia in pediatric dialysis patients in Taiwan.
    Lin CY; Lin JY; Chen WP
    Nephron; 1993; 65(4):654. PubMed ID: 7508095
    [No Abstract]   [Full Text] [Related]  

  • 20. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
    Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
    Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.